Compare Unity Software Inc (U) vs Vertex Pharmaceuticals Incorporated (VRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Unity Software Inc vs Vertex Pharmaceuticals Incorporated — how do they compare? Unity Software Inc trades at $29.78 (market cap $13.01B), while Vertex Pharmaceuticals Incorporated trades at $478.06 (market cap $121.95B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 9.4× Unity Software Inc's market cap, and Vertex Pharmaceuticals Incorporated is trading nearer its 52-week high, Unity Software Inc nearer its low. Which is the better fit depends on your goals.
| U | VRTX | |
|---|---|---|
Market Cap | $13.01B | $121.95B |
Sector | Technology | Health |
52-Week High | $49.47 | $529.59 |
52-Week Low | $17.13 | $366.54 |
Enterprise Value | $13.11B | $116.69B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Unity Software (U) trades at $29.87, up 3.04% today, showing bullish technical momentum above key support levels. The company maintains strong revenue of $1.85B with improving gross margins at 62.79%, though net losses persist at -$402.77M. Recent Unity 7 platform announcements and AI integration focus signal strategic growth initiatives. Analyst consensus remains strongly bullish with 69% buy ratings and $36.50 price target, representing 22% upside potential from current levels.
Unity presents a growth opportunity with improving financial trends and strong institutional support, but faces execution risks in profitability turnaround. The stock's elevated valuation multiples (P/S 6.61, EV/EBITDA 134.62) require sustained revenue growth justification. Near-term catalyst includes Q2 2026 earnings on August 5, where analysts expect EPS of $0.24 after recent misses.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Unity Software Inc
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →
